Israel - English - Ministry of Health

fischer pharmaceuticals ltd - povidone-iodine - ointment - povidone-iodine 10 %w/w - povidone-iodine - povidone-iodine - for the disinfection of skin infections , wounds and superficial burns.

Israel - English - Ministry of Health

fischer pharmaceuticals ltd - povidone-iodine - pessary - povidone-iodine 5 % - povidone-iodine - povidone-iodine - treatment of vaginal infections caused by fungi, trichomonas, bacteria or mixed infections.

Israel - English - Ministry of Health

fischer pharmaceuticals ltd - povidone-iodine - solution - external - povidone-iodine 10 % - iodine products - antiseptic for use in first aid in wounds, scratches, mild burns. for treatment of skin infections caused by bacteria or fungi. antiseptic vaginal douche.

Israel - English - Ministry of Health

fischer pharmaceuticals ltd - povidone-iodine - solution - external - povidone-iodine 7.5 %w/v - povidone-iodine - povidone-iodine - wound disinfection to prevent skin infections caused by bacteria and fungi, disinfection of infected skin conditions and sidinfection of the hands before medical procedures.

Malta - English - Medicines Authority

bell sons & co. (druggists) limited gifford house, slaidburn crescent, southport, mersyside pr 9 9al, united kingdom - benzyl benzoate - cutaneous solution - benzyl benzoate 25 % (w/v) - ectoparasiticides, incl. scabicides, insecticides and repellents

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - for treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

United States - English - NLM (National Library of Medicine)

westminster pharmaceuticals, llc - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - for treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - for treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals, llc - probenecid (unii: po572z7917) (probenecid - unii:po572z7917), colchicine (unii: sml2y3j35t) (colchicine - unii:sml2y3j35t) - for the treatment of chronic gouty arthritis when complicated by frequent, recurrent acute attacks of gout. hypersensitivity to this product or to probenecid or colchicine. probenecid and colchicine tablets are contraindicated in children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid and colchicine should not be started until an acute gouty attack has subsided. pregnancy: probenecid crosses the placental barrier and appears in cord blood. colchicine can arrest cell division in animals and plants. in certain species of animals under certain conditions, colchicine has produced teratogenic effects. the possibility of such effects in humans also has been reported. because of the colchicine component, probenecid and colchicine is contraindicated in pregnant patients. the use of any drug in women of childbearing potential requires that the anticipated benefit be weighed against the possible hazards.

United States - English - NLM (National Library of Medicine)

neurocrine biosciences, inc. - valbenazine tosylate (unii: 5sml1t733b) (valbenazine - unii:54k37p50kh) - valbenazine 40 mg - ingrezza is indicated for the treatment of adults with: - tardive dyskinesia [see clinical studies ( 14.1 )] . - chorea associated with huntington’s disease [see clinical studies ( 14.2 )] . ingrezza is contraindicated in patients with a history of hypersensitivity to valbenazine or any components of ingrezza. rash, urticaria, and reactions consistent with angioedema (e.g., swelling of the face, lips, and mouth) have been reported [see warnings and precautions ( 5.2 ) and adverse reactions ( 6.2 )]. risk summary the limited available data on ingrezza use in pregnant women are insufficient to inform a drug-associated risk. in animal reproductive studies, no malformations were observed when valbenazine was administered orally to rats and rabbits during the period of organogenesis at doses up to 1.8 or 24 times, respectively, the maximum recommended human dose (mrhd) of 80 mg/day based on mg/m2 body surface area. however, administration of valbenazine to pregnant rats during organogenesis through lactation p